DKSH signed global exclusive agreement to distribute Hanseo Chemical's GPC

07-Nov-2011 - Korea, Republic of (South Korea)

The agreement signed between DKSH’s Business Unit Performance Materials and HanseoChem is a global partnership where DKSH will sell and market HanseoChem's GPC (Glycerophosphatidylcholin) to the pharmaceutical industry worldwide.

HanseoChem has chosen DKSH for its excellent knowledge of the pharmaceutical market, the registration support, and the high-end procurement capability. Leveraging on its well-established worldwide network, DKSH will help HanseoChem grow its business and enhance its product coverage around the globe. In addition, DKSH will also support HanseoChem to develop and expand their soy derived Active Pharmaceutical Ingredients (APIs) business in the near future.

Leading Korean manufacturer HanseoChem is one among only a few companies that is able to produce GPC under Good Manufacturing Practices conditions in their own high tech manufacturing site. The GPC is proven to meet the highest quality standards required in the pharmaceutical industry. HanseoChem’s high-quality APIs and intermediates are widely used for drug formulation in the market.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances